Synapse - Sergio Giralt

Results (1065)

Phase II study of infusional carfilzomib in patients with relapsed or refractory multiple myeloma

Meeting Abstract

Lendvai, N.; Landau, H.; Lesokhin, A.; Tsakos, I.; Koehne, G.; Chung, D.; Devlin, S.; Hassoun, H.; Giralt, S. A.
Blood (2012)

Fulltext@MSK | Save

Low dose azacitidine maintenance therapy following allogeneic stem cell transplantation for MDS/AML does not interact with tacrolimus dosing or serum levels

Meeting Abstract

Lee, H. C.; Howell, J.; Milton, D.; Giralt, S. A.; Chen, J. J.; Rondon, G.; Champlin, R. E.; Parmar, S.; de Lima, M.
Blood (2012)

Fulltext@MSK | Save

Risk-adapted melphalan and stem cell transplant for systemic light chain amyloidosis: A single institution experience

Meeting Abstract

Landau, H.; Fein, D. E.; Hassoun, H.; Bello, C.; Chou, J. F.; Devlin, S.; Giralt, S.; Comenzo, R. L.
Blood (2012)

Fulltext@MSK | Save

Adoptive immunotherapy with donor T cells sensitized with overlapping pentadecapeptides of the CMV-pp65 protein for the treatment of persistent CMV antigenemia following allogeneic hematopoietic stem cell transplants

Meeting Abstract

Koehne, G.; Hasan, A. N.; Doubrovina, E.; Tyler, E.; Prockop, S. E.; Barker, J. N.; Castro-Malaspina, H. R.; Perales, M. A.; Sauter, C. S.; Jakubowski, A. A.; more...
Blood (2012)

Fulltext@MSK | Save

Sirolimus, tacrolimus and low-dose methotrexate based graft-versus-host disease (GVHD) prophylaxis after non-ablative or reduced intensity conditioning in related and unrelated donor allogeneic stem cell transplantation: Decreased severe early aGVHD but persistence of late acute GVHD

Meeting Abstract

Izaskun, C.; Devlin, S.; Sauter, C. S.; Barker, J. N.; Castro-Malaspina, H.; Giralt, S. A.; Ponce, D. M.; Lechner, L.; Gonzales, A. M. R.; Goldberg, J. D.; more...
Blood (2012)

Fulltext@MSK | Save

EBMT risk score for pre transplant risk assessment in patients with multiple myeloma

Meeting Abstract

Gul, Z.; Khan, H.; Bashir, Q.; Shah, N.; Parmar, S.; Dinh, Y. T.; Hosing, C. M.; Popat, U. R.; Kebriaei, P.; Anderlini, P.; more...
Blood (2012)

Fulltext@MSK | Save

Cardiac toxicity after high-dose melphlan and autologous hematopoietic stem cell transplantation for multiple myeloma

Meeting Abstract

Gul, Z.; Bashir, Q.; Nieto, Y.; Sherwani, N.; Parmar, S.; Shah, N.; Dinh, Y. T.; Hosing, C. M.; Popat, U. R.; Kebriaei, P.; more...
Blood (2012)

Fulltext@MSK | Save

A phase II study of allogeneic transplantation for older patients with AML in first complete remission using a reduced intensity conditioning regimen: Results from CALGB 100103/BMT CTN 0502

Meeting Abstract

Devine, S. M.; Owzar, K.; Blum, W.; DeAngelo, D.; Stone, R. M.; Hsu, J. W.; Champlin, R. E.; Chen, Y. B. A.; Vij, R.; Slack, J. L.; more...
Blood (2012)

Fulltext@MSK | Save

Low dose azacitidine (AZA) reduces the incidence of chronic graft-versus-host disease (cGVHD) after allogeneic hematopoietic stem cell transplantation (HSCT)